Actively Recruiting
A Study of YUTIQ® 0.18 mg Intravitreal Implant for the Management of Chronic Non-infectious Uveitis
Led by Tianjin Medical University · Updated on 2024-07-03
15
Participants Needed
1
Research Sites
199 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This project is designed to evaluate the efficacy of YUTIQ® 0.18 mg intravitreal implant for the management of chronic non-infectious uveitis.
CONDITIONS
Official Title
A Study of YUTIQ® 0.18 mg Intravitreal Implant for the Management of Chronic Non-infectious Uveitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female in good general health aged 18 to 70 years
- Presence of unilateral or bilateral non-infectious uveitis affecting the posterior segment
- Active inflammation before YUTIQ treatment, meeting at least one of these: 651+ anterior chamber cell and/or 651+ vitreous haze, fluorescein angiography leakages, OCT showing macular edema, or three or more relapses in one year
- Steroids and immunosuppressive agents discontinued within 3 months after YUTIQ injection
You will not qualify if you...
- Corneal or lens opacity blocking fundus view or likely needing cataract surgery during the study
- History of neurological symptoms suggesting central nervous system demyelinating disease
- Prior intravitreal treatment with Retisert, ILUVIEN, or YUTIQ within 36 months before Day 1
- Prior intravitreal treatment with OZURDEX, Triesence, or TRIVARIS within 12 weeks before Day 1
- Peri-ocular or subtenon steroid treatment within 12 weeks before Day 1
- Media opacity preventing retina and vitreous evaluation (e.g., vitreous hemorrhage)
- Hypersensitivity to any ingredients in YUTIQ
- Any systemic or eye condition making the subject unsuitable for the study
- Pregnant or nursing females; females of childbearing potential unwilling or unable to use acceptable contraception from 14 days before Day 1 until study end
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tianjin Medical University Eye Hospital
Tianjin, Tianjin Municipality, China, 300000
Actively Recruiting
Research Team
X
xiaomin Zhang
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here